Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Jan;60(1):55–60. doi: 10.1136/ard.60.1.55

Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs

J Haapala 1, J Arokoski 1, S Ronkko 1, U Agren 1, V Kosma 1, L Lohmander 1, M Tammi 1, H Helminen 1, I Kiviranta 1
PMCID: PMC1753360  PMID: 11114283

Abstract

OBJECTIVE—To monitor the concentration of markers of cartilage and synovium metabolism in the knee (stifle) joint synovial fluid of young beagles subjected to immobilisation and subsequent remobilisation.
METHODS—The right hind limb of 17 dogs was immobilised in flexion for 11 weeks. Simultaneously, the contralateral left knee was exposed to increased weight bearing. The remobilisation period lasted 50 weeks. Litter mates served as controls. The concentration in joint lavage fluid of interleukin 1α (IL1α) was measured by immunoassay, the activity of phospholipase A2 (PLA2) was determined by an extraction method, chondroitin sulphate (CS) concentration by precipitation with Alcian blue, hyaluronan (HA) by an ELISA-like assay using biotinylated HA-binding complexes, matrix metalloproteinase 3 (MMP-3), and tissue inhibitor of metalloproteinases 1 (TIMP-1) by sandwich ELISA, and synovitis was scored by light microscopy.
RESULTS—Synovitis or effusion was absent in all experimental and control groups. Immobilisation decreased the joint lavage fluid levels of IL1α (p<0.05), TIMP (p< 0.05), and the concentration of CS down to 38% (p<0.05) in comparison with untreated litter mates with normal weight bearing. Immobilisation did not affect the activity of PLA2, or the concentration of MMP-3 or HA in synovial fluid. Joint remobilisation restored the decreased concentrations of markers to control levels. Increased weight bearing did not change the concentrations of markers in comparison with the control joints with normal weight bearing.
CONCLUSIONS—11 weeks' joint immobilisation decreased the concentration of markers of cartilage and synovium metabolism in the synovial fluid, and remobilisation restored the concentrations to control levels. The changes in joint metabolism induced by immobilisation, as reflected by the markers, are thus different from those found in osteoarthritis, where increased levels of these markers are associated with enhanced degradation and synthesis. These findings suggest that the change induced in joint metabolism by immobilisation is reversible in its early stages.



Full Text

The Full Text of this article is available as a PDF (138.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayne E. K., Hutchinson N. I., Walakovits L. A., Donatelli S., MacNaul K. L., Harper C. F., Cameron P., Moore V. L., Lark M. W. Production, purification and characterization of canine prostromelysin. Matrix. 1992 Jun;12(3):173–184. doi: 10.1016/s0934-8832(11)80059-4. [DOI] [PubMed] [Google Scholar]
  2. Björnsson S. Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem. 1993 May 1;210(2):282–291. doi: 10.1006/abio.1993.1197. [DOI] [PubMed] [Google Scholar]
  3. Bomalaski J. S., Lawton P., Browning J. L. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol. 1991 Jun 1;146(11):3904–3910. [PubMed] [Google Scholar]
  4. Brackertz D., Vischer T. L. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study. J Rheumatol. 1989 Jan;16(1):19–23. [PubMed] [Google Scholar]
  5. Brinckerhoff C. E. Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis Rheum. 1991 Sep;34(9):1073–1075. doi: 10.1002/art.1780340902. [DOI] [PubMed] [Google Scholar]
  6. Carney S. L., Billingham M. E., Caterson B., Ratcliffe A., Bayliss M. T., Hardingham T. E., Muir H. Changes in proteoglycan turnover in experimental canine osteoarthritic cartilage. Matrix. 1992 Apr;12(2):137–147. doi: 10.1016/s0934-8832(11)80055-7. [DOI] [PubMed] [Google Scholar]
  7. Clark I. M., Powell L. K., Ramsey S., Hazleman B. L., Cawston T. E. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1993 Mar;36(3):372–379. doi: 10.1002/art.1780360313. [DOI] [PubMed] [Google Scholar]
  8. Coleman P. J., Scott D., Ray J., Mason R. M., Levick J. R. Hyaluronan secretion into the synovial cavity of rabbit knees and comparison with albumin turnover. J Physiol. 1997 Sep 15;503(Pt 3):645–656. doi: 10.1111/j.1469-7793.1997.645bg.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooksley S., Hipkiss J. B., Tickle S. P., Holmes-Ievers E., Docherty A. J., Murphy G., Lawson A. D. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes. Matrix. 1990 Oct;10(5):285–291. doi: 10.1016/s0934-8832(11)80183-6. [DOI] [PubMed] [Google Scholar]
  10. Dahl L. B., Dahl I. M., Engström-Laurent A., Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985 Dec;44(12):817–822. doi: 10.1136/ard.44.12.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Flannery C. R., Lark M. W., Sandy J. D. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem. 1992 Jan 15;267(2):1008–1014. [PubMed] [Google Scholar]
  12. Grassi J., Frobert Y., Pradelles P., Chercuitte F., Gruaz D., Dayer J. M., Poubelle P. E. Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Methods. 1989 Oct 24;123(2):193–210. doi: 10.1016/0022-1759(89)90223-8. [DOI] [PubMed] [Google Scholar]
  13. Grumbles R. M., Howell D. S., Howard G. A., Roos B. A., Setton L. A., Mow V. C., Ratcliffe A., Muller F. J., Altman R. D. Cartilage metalloproteases in disuse atrophy. J Rheumatol Suppl. 1995 Feb;43:146–148. [PubMed] [Google Scholar]
  14. Haapala J., Arokoski J. P., Hyttinen M. M., Lammi M., Tammi M., Kovanen V., Helminen H. J., Kiviranta I. Remobilization does not fully restore immobilization induced articular cartilage atrophy. Clin Orthop Relat Res. 1999 May;(362):218–229. [PubMed] [Google Scholar]
  15. Haapala J., Arokoski J., Pirttimäki J., Lyyra T., Jurvelin J., Tammi M., Helminen H. J., Kiviranta I. Incomplete restoration of immobilization induced softening of young beagle knee articular cartilage after 50-week remobilization. Int J Sports Med. 2000 Jan;21(1):76–81. doi: 10.1055/s-2000-8860. [DOI] [PubMed] [Google Scholar]
  16. Haapala J., Lammi M. J., Inkinen R., Parkkinen J. J., Agren U. M., Arokoski J., Kiviranta I., Helminen H. J., Tammi M. I. Coordinated regulation of hyaluronan and aggrecan content in the articular cartilage of immobilized and exercised dogs. J Rheumatol. 1996 Sep;23(9):1586–1593. [PubMed] [Google Scholar]
  17. Hutchinson N. I., Lark M. W., MacNaul K. L., Harper C., Hoerrner L. A., McDonnell J., Donatelli S., Moore V., Bayne E. K. In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1 beta. Arthritis Rheum. 1992 Oct;35(10):1227–1233. doi: 10.1002/art.1780351016. [DOI] [PubMed] [Google Scholar]
  18. Jortikka M. O., Inkinen R. I., Tammi M. I., Parkkinen J. J., Haapala J., Kiviranta I., Helminen H. J., Lammi M. J. Immobilisation causes longlasting matrix changes both in the immobilised and contralateral joint cartilage. Ann Rheum Dis. 1997 Apr;56(4):255–261. doi: 10.1136/ard.56.4.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kiviranta I., Jurvelin J., Tammi M., Sämänen A. M., Helminen H. J. Weight bearing controls glycosaminoglycan concentration and articular cartilage thickness in the knee joints of young beagle dogs. Arthritis Rheum. 1987 Jul;30(7):801–809. doi: 10.1002/art.1780300710. [DOI] [PubMed] [Google Scholar]
  20. Kongtawelert P., Ghosh P. A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal Biochem. 1990 Mar;185(2):313–318. doi: 10.1016/0003-2697(90)90300-x. [DOI] [PubMed] [Google Scholar]
  21. Kortekangas P., Aro H. T., Nevalainen T. J. Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand J Rheumatol. 1994;23(2):68–72. doi: 10.3109/03009749409103030. [DOI] [PubMed] [Google Scholar]
  22. Lohmander L. S., Hoerrner L. A., Lark M. W. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 1993 Feb;36(2):181–189. doi: 10.1002/art.1780360207. [DOI] [PubMed] [Google Scholar]
  23. Lohmander L. S., Neame P. J., Sandy J. D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 1993 Sep;36(9):1214–1222. doi: 10.1002/art.1780360906. [DOI] [PubMed] [Google Scholar]
  24. Lohmander L. S. What is the current status of biochemical markers in the diagnosis, prognosis and monitoring of osteoarthritis? Baillieres Clin Rheumatol. 1997 Nov;11(4):711–726. doi: 10.1016/s0950-3579(97)80006-4. [DOI] [PubMed] [Google Scholar]
  25. Lotz M., Guerne P. A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem. 1991 Feb 5;266(4):2017–2020. [PubMed] [Google Scholar]
  26. MacNaul K. L., Chartrain N., Lark M., Tocci M. J., Hutchinson N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem. 1990 Oct 5;265(28):17238–17245. [PubMed] [Google Scholar]
  27. Messner K., Gillquist J., Björnsson S., Lohmander L. S. Proteoglycan fragments in rabbit joint fluid correlated to arthrosis stage. Acta Orthop Scand. 1993 Jun;64(3):312–316. doi: 10.3109/17453679308993633. [DOI] [PubMed] [Google Scholar]
  28. Müller F. J., Setton L. A., Manicourt D. H., Mow V. C., Howell D. S., Pita J. C. Centrifugal and biochemical comparison of proteoglycan aggregates from articular cartilage in experimental joint disuse and joint instability. J Orthop Res. 1994 Jul;12(4):498–508. doi: 10.1002/jor.1100120406. [DOI] [PubMed] [Google Scholar]
  29. OGSTON A. G., STANIER J. E. The physiological function of hyaluronic acid in synovial fluid; viscous, elastic and lubricant properties. J Physiol. 1953 Feb 27;119(2-3):244–252. doi: 10.1113/jphysiol.1953.sp004842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Panula H. E., Lohmander L. S., Rönkkö S., Agren U., Helminen H. J., Kiviranta I. Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs. Acta Orthop Scand. 1998 Apr;69(2):152–158. doi: 10.3109/17453679809117617. [DOI] [PubMed] [Google Scholar]
  31. Pradelles P., Grassi J., Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem. 1985 Jun;57(7):1170–1173. doi: 10.1021/ac00284a003. [DOI] [PubMed] [Google Scholar]
  32. Pruzanski W., Vadas P., Stefanski E., Urowitz M. B. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol. 1985 Apr;12(2):211–216. [PubMed] [Google Scholar]
  33. Ratcliffe A., Beauvais P. J., Saed-Nejad F. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse. J Orthop Res. 1994 Jul;12(4):464–473. doi: 10.1002/jor.1100120403. [DOI] [PubMed] [Google Scholar]
  34. Ratcliffe A., Shurety W., Caterson B. The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum. 1993 Apr;36(4):543–551. doi: 10.1002/art.1780360416. [DOI] [PubMed] [Google Scholar]
  35. Revell P. A., Mayston V., Lalor P., Mapp P. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis. 1988 Apr;47(4):300–307. doi: 10.1136/ard.47.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rönkkö S., Lahtinen R., Vanha-Perttula T. Phospholipases A2 in the reproductive system of the bull. Int J Biochem. 1991;23(5-6):595–603. doi: 10.1016/0020-711x(87)90054-1. [DOI] [PubMed] [Google Scholar]
  37. Sandy J. D., Adams M. E., Billingham M. E., Plaas A., Muir H. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum. 1984 Apr;27(4):388–397. doi: 10.1002/art.1780270405. [DOI] [PubMed] [Google Scholar]
  38. Scott D., Coleman P. J., Mason R. M., Levick J. R. Glycosaminoglycan depletion greatly raises the hydraulic permeability of rabbit joint synovial lining. Exp Physiol. 1997 May;82(3):603–606. doi: 10.1113/expphysiol.1997.sp004050. [DOI] [PubMed] [Google Scholar]
  39. Vadas P., Pruzanski W., Kim J., Fornasier V. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Am J Pathol. 1989 Apr;134(4):807–811. [PMC free article] [PubMed] [Google Scholar]
  40. Vadas P., Stefanski E., Pruzanski W. Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid. Life Sci. 1985 Feb 11;36(6):579–587. doi: 10.1016/0024-3205(85)90640-x. [DOI] [PubMed] [Google Scholar]
  41. Venn G., Nietfeld J. J., Duits A. J., Brennan F. M., Arner E., Covington M., Billingham M. E., Hardingham T. E. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum. 1993 Jun;36(6):819–826. doi: 10.1002/art.1780360613. [DOI] [PubMed] [Google Scholar]
  42. Walakovits L. A., Moore V. L., Bhardwaj N., Gallick G. S., Lark M. W. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum. 1992 Jan;35(1):35–42. doi: 10.1002/art.1780350106. [DOI] [PubMed] [Google Scholar]
  43. Wang C., Tammi M., Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry. 1992 Sep;98(2):105–112. doi: 10.1007/BF00717001. [DOI] [PubMed] [Google Scholar]
  44. Wu J. J., Lark M. W., Chun L. E., Eyre D. R. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991 Mar 25;266(9):5625–5628. [PubMed] [Google Scholar]
  45. van den Berg W. B. Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin Immunopathol. 1998;20(1-2):149–164. doi: 10.1007/BF00832004. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES